Diagnostics for oncology


Cancer is one of the leading causes of death worldwide. Despite our advancing knowledge of cancer, there is still a need for additional information for the management of the disease. Improvement in patient care can be expected if clinicians have more information on prognosis, early indications of treatment response, and disease progression.

To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.

In vitro diagnostic biomarkers are non-invasive, highly accurate, and cost-effective, and can be used in various types of cancer, such as breast, bladder, and prostate cancer. The biomarkers offer enhanced sensitivity and reduced lead times.


UBC® Rapid | Bladder Cancer Detection

IDL Biotech’s UBC® Rapid is a powerful Point-of-Care test for primary diagnosis and monitoring of bladder cancer.

tps tumor activity marker

TK 210 ELISA | Cell Proliferation Biomarker

The AroCell TK 210 ELISA kit is a valuable biomarker for tumor cell turnover that aids in prognosis and monitoring therapy.

tps tumor activity marker
tps tumor activity marker

Tumor markers licensed to strategical partners

AroCell’s is constantly seeking partners for establishing projects and developing new products to expand its portfolio.

tps tumor activity marker

An effective typhoid test

Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella enterica. IDL Biotechs product TUBEX® TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.


We are listed on NASDAQ First North Growth Market.

We want to be the obvious choice within our segment in the markets where we are established. The market for our products is large and we are a smaller player with significant growth potential so far. AroCell is unique for a company of this size.